U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07908836) titled 'PBM and Hip Fracture' on Oct. 22.
Brief Summary: The main objective of this study was to describe the application of PBM strategies in patients undergoing surgery for hip fractures, their outcomes between 2022 and 2024, and the factors associated with the transfusion of red blood cell concentrates. As secondary objectives, the study analysed the factors associated with surgical delay, particularly prior oral anticoagulation, as well as post-operative delirium, in-hospital complications, prolonged hospital stay and mortality at 30 days, 6 months and 1 year.
Translated with DeepL.com (free version)
Study Start Date: Jan. 01, 2022
St...